Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00984022 · ClinicalTrials.gov registry record · Phase 2

Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage

A Phase 2 study of Abscess and Cellulitis, sponsored by Valleywise Health.

Completed
Registry status
Phase 2
Development phase
92
Enrollment target
1
Study location

NCT00984022 is a Phase 2 study of Abscess and Cellulitis that has completed, run by Valleywise Health. The registered enrollment target is 92 participants, below the 383-participant average among 13 other Abscess trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00984022, a Phase 2 study of Abscess and Cellulitis, has completed, sponsored by Valleywise Health.

COMPLETED
Registry status
Phase 2
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess.

Conditions Studied

Interventions

  • DEVICE Type of dressing - Iodoform
  • DEVICE Type of dressing - Aquacel

Study Locations (1)

Arizona

  • Maricopa Integrated Health System - Phoenix

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2008-03
Est. Completion 2010-02-23
Phase Phase 2

Sponsor

Valleywise Health

9 total trials

What the Registry Record Tells You About NCT00984022

The ClinicalTrials.gov registry entry for NCT00984022 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 383-participant average among 13 other Abscess trials with a reported enrollment target (76% lower). The listed sponsor is Valleywise Health, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Abscess appearing as the primary indexed condition, and to 2 interventions - of which Type of dressing - Iodoform is the first listed.

NCT00984022 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT00984022 about?

NCT00984022 is a clinical study titled "Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage". This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess.

What is the current status of trial NCT00984022?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2008-03. Estimated completion is 2010-02-23.

What conditions does trial NCT00984022 study?

This clinical trial studies the following conditions: Abscess, Cellulitis.

What interventions are being tested in trial NCT00984022?

The interventions under investigation include: Type of dressing - Iodoform (DEVICE), Type of dressing - Aquacel (DEVICE).

Who is sponsoring clinical trial NCT00984022?

This trial is sponsored by Valleywise Health, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00984022 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abscess

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.